ConforMIS has developed the only line of personalized, partial knee resurfacing implants to treat knee osteoarthritis, one of the most common conditions facing our aging population. ConforMIS is a privately held medical device company based in Massachusetts. It was founded in 2004 to provide dramatic advancements in patient care by utilizing imaging technology to create personalized, patient-specific implants and instrumentation. ConforMIS transforms traditional CT and MRI data into patient-specific implants and instrumentation employing two related ‘image-to-implant’ technology platforms. Both platforms are supported by proprietary, intellectual property consisting of more than 250 patents and pending patent applications that span imaging software, image processing, implant design, surgical techniques and orthopedic instrumentation. The technology and patent portfolio is applicable to all major joint systems. To date, ConforMIS has developed a comprehensive line of minimally traumatic implant solutions to address all stages of knee osteoarthritis, the most common reason for knee replacement surgery. Each of these devices has been cleared for marketing by the US Food and Drug Administration. Certain ConforMIS implants have also received CE Marking for the European region.
Bedford, US
Size (employees)
383 (est)-1%
ConforMIS was founded in 2004 and is headquartered in Bedford, US

Key People at ConforMIS

Amita Shah

Amita Shah

Vice President, Regulatory and Quality Affairs
John Slamin

John Slamin

Senior Vice President, Knee Implant Engineering
David Cerveny

David Cerveny

Senior Vice President, Intellectual Property & General Counsel
Rob Law

Rob Law

Senior Vice President, Sales
Adam Hayden

Adam Hayden

Vice President, Marketing

ConforMIS Office Locations

ConforMIS has an office in Bedford
Bedford, US (HQ)
28 Crosby Dr

ConforMIS Data and Metrics

ConforMIS Financial Metrics

ConforMIS's revenue was reported to be $79.9 m in FY, 2016 which is a 19% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

79.9 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

26.7 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(57.6 m)

EBIT (FY, 2016)

(56.1 m)

Market capitalization (22-Jun-2017)

181.5 m

Closing share price (22-Jun-2017)


Cash (31-Dec-2016)

37.3 m
ConforMIS's current market capitalization is $181.5 m.
FY, 2015FY, 2016


66.9 m79.9 m

Revenue growth, %


Cost of goods sold

42.4 m53.2 m

Gross profit

24.5 m26.7 m

Gross profit Margin, %


Sales and marketing expense

40.2 m41.1 m

R&D expense

17 m16.6 m

General and administrative expense

23.2 m25.2 m

Operating expense total

80.4 m82.9 m


(56 m)(56.1 m)

EBIT margin, %


Interest expense

(1.4 m)(138 k)

Interest income

138 k487 k

Pre tax profit

(57.2 m)(57.5 m)

Income tax expense

41 k63 k

Net Income

(57.2 m)(57.6 m)
FY, 2015FY, 2016


117.2 m37.3 m

Accounts Receivable

14.9 m14.7 m


11.5 m11.7 m

Current Assets

146 m95.8 m


11 m15.1 m


753 k753 k

Total Assets

159.4 m112.8 m

Accounts Payable

4.7 m5.5 m

Total Debt

478 k

Current Liabilities

13.1 m14.3 m

Additional Paid-in Capital

467.1 m476.5 m

Retained Earnings

(325.3 m)(382.9 m)

Total Equity

141.2 m94.1 m

Debt to Equity Ratio

0 x

Debt to Assets Ratio

0 x

Financial Leverage

1.1 x1.2 x
FY, 2015FY, 2016

Net Income

(57.2 m)(57.6 m)

Depreciation and Amortization

2.6 m3.2 m

Accounts Receivable

(6.1 m)4 k


(3.8 m)(200 k)

Accounts Payable

(8.7 m)

Cash From Operating Activities

(54.5 m)(49.1 m)

Purchases of PP&E

(4.6 m)(7.2 m)

Cash From Investing Activities

(806 k)(35.4 m)

Long-term Borrowings

(10.3 m)(485 k)

Cash From Financing Activities

134.6 m3.6 m

Interest Paid

1.3 m48 k

Income Taxes Paid

187 k52 k
Numbers are in $, USDY, 2016


206.5 k

Financial Leverage

1.2 x

ConforMIS Market Value History

ConforMIS Online and Social Media Presence

ConforMIS News and Updates

ConforMIS Company Life and Culture

You may also be interested in